For example, one recent study showed that TMEM106B knockdown is neuroprotective in both in vitro and in vivo Parkinson’s disease models, and another study found that loss of TMEM106B exacerbates tau pathology and neurodegeneration in an FTD model [20, 49]. Here, MAPT is linked to frontotemporal dementia.